Risk factors of severe hypoglycaemia in adult patients with type I diabetes–a prospective population based study
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The objective of this study was to identify possible risk factors of severe hypoglycaemia (SH) in a prospective population based study of adult Type I (insulin-dependent) diabetic patients. A representative sample of 684 patients (41% women, mean +/- SD age 36 +/- 11, diabetes duration 18 +/- 11 years), living in the district of Northrhine (9.5 million inhabitants), Germany, were examined in their homes using a mobile ambulance. A comprehensive baseline assessment of possible predictors of SH included sociodemographic and disease related variables, hypoglycaemia awareness, diabetes management, and attitudes and behavioural aspects as expressed by the patients. After a mean of 19 +/- 6 months 669 (98%) patients were interviewed about events of SH since the baseline examination. Using the multiple Cox proportional hazards model, five risk factors of SH were identified: SH during the preceding year [hazard ratio (HR) 2.7, 95% confidence intervals (CI) 1.8-4.2], any history of SH (HR 1.9, CI 1.1-3.4), C-peptide negativity (HR 4.0, CI 1.2-12.7), social status (HR 0.8 for a difference of 5 units for a value range of 0-24, CI 0.6-0.9), and patients' determination to reach normoglycaemia (HR 0.7 for a difference of 1 unit for a value range of 1-6, CI 0.5-0.9), indicating that the lower the social status and the higher the patients' determination to reach normoglycaemia, the higher the risk of SH. After eliminating the history of hypoglycaemia from the model, impaired hypoglycaemia awareness and patients' inappropriate denial of SH as their particular problem became additional significant risk factors of SH. In conclusion, in this population based study of adult Type I diabetic patients, C-peptide negativity, a previous event of SH, patients' determination to reach normoglycaemia and social class were risk factors of SH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297 · cited 2×
“The Cox proportional hazards model [15] was applied to investigate the effects of a number of explanatory variables on the risk of hypoglycaemia.”
MethodLimited-dependent and qualitative variables in econometrics
Maddala, G. S. (1983) · Cambridge University Press eBooks · doi:10.1017/cbo9780511810176 · Cited by 13,240 · cited 1×
“tion in survival analyses because of its values being too low [17], the likelihood ratio R2 [ 18 , 19] was also calculated.”
BackgroundJournal of the Royal Statistical Society (B)
Fildes, R. (1993) · International Journal of Forecasting · doi:10.1016/0169-2070(93)90088-5 · Cited by 3,437
Limited-Dependent and Qualitative Variables in Econometrics.
Schmidt, P., & Maddala, G. S. (1984) · Journal of the American Statistical Association · doi:10.2307/2288445 · Cited by 1,310
Gold, A. E., Macleod, K. M., & Frier, B. M. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.697 · Cited by 810
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
White, N. H., Skor, D. A., Cryer, P. E., Levandoski, L. A., Bier, D. M., & Santiago, J. V. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303033080903 · Cited by 391
On the Estimation of Relationships Involving Qualitative Variables
Theil, H. (1970) · American Journal of Sociology · doi:10.1086/224909 · Cited by 373 · cited 1×
“To compare our results with those of the DCCT [2], the entropy R2 [2, 16] was used.”
ResultR 2 Measures Based on Wald and Likelihood Ratio Joint Significance Tests
Magee, L. (1990) · The American Statistician · doi:10.1080/00031305.1990.10475731 · Cited by 368
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Cryer, P. E., Davis, S. N., & Shamoon, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1902 · Cited by 1,160
“In addition to those that lead to absolute or relative insulin excess—insulin or other drug doses, timing, and type; patterns of food ingestion and exercise; interactions with alcohol or other drugs; altered sensitivity to, or clearance of, insulin—these include risk factors for compromised glucose counterregulation (…”
BackgroundHypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes.
Cryer, P. (2002) · Diabetologia · doi:10.1007/s00125-002-0822-9 · Cited by 794
“Risk factors related to compromised glucose counterregulation that are well established in Type I diabetes [1, 23, 58 ] and are likely to be relevant in advanced Type II diabetes, include: (i) insulin deficiency; (ii) a history of severe hypoglycaemia, hypoglycaemia unawareness, or both; (iii) aggressive glycaemic the…”
BackgroundThe barrier of hypoglycemia in diabetes
Cryer, P. E. (2008) · Diabetes · doi:10.2337/db08-1084 · Cited by 725
Donnelly, L. A., Morris, A. D., Frier, B. M., Ellis, J. D., Donnan, P. T., Durrant, R., Band, M. M., Reekie, G., & Leese, G. P. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01501.x · Cited by 511
Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications
Frier, B. M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.170 · Cited by 481
Pedersen‐Bjergaard, U., Pramming, S., Heller, S. R., Wallace, T. M., Rasmussen, Å. K., Jørgensen, H. V., Matthews, D. R., Hougaard, P., & Thorsteinsson, B. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.482 · Cited by 371
Horvath, K., Jeitler, K., Berghold, A., Ebrahim, S. H., Gratzer, T. W., Plank, J., Kaiser, T., Pieber, T. R., & Siebenhofer, A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005613.pub3 · Cited by 366
Insulin analogues and their potential in the management of diabetes mellitus
Bolli, G. B., Di Marchi, R. D., Park, G. D., Pramming, S., & Koivisto, V. A. (1999) · Diabetologia · doi:10.1007/s001250051286 · Cited by 349
Weinstock, R. S., Xing, D., Maahs, D. M., Michels, A., Rickels, M. R., Peters, A. L., Bergenstal, R. M., Harris, B., DuBose, S. N., Miller, K. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1589 · Cited by 338
Hypoglycaemia in insulin‐treated Type 2 diabetes: frequency, symptoms and impaired awareness
Henderson, J. N., Allen, K. V., Deary, I. J., & Frier, B. M. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01072.x · Cited by 287
Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus
Siebenhofer, A., Plank, J., Berghold, A., Jeitler, K., Horvath, K., Narath, M., Gfrerer, R., & Pieber, T. R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003287.pub4 · Cited by 264
Recall of severe hypoglycaemia and self‐estimated state of awareness in type 1 diabetes
Pedersen‐Bjergaard, U., Pramming, S., & Thorsteinsson, B. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.377 · Cited by 240
Hypoglycemia: Still The Limiting Factor in the Glycemic Management of Diabetes
Cryer, P. E. (2008) · Endocrine Practice · doi:10.4158/ep.14.6.750 · Cited by 186
Hypoglycemia in Type 1 and Type 2 Diabetes: Physiology, Pathophysiology,and Management
Briscoe, V. J., & Davis, S. N. (2006) · Clinical Diabetes · doi:10.2337/diaclin.24.3.115 · Cited by 174
Maternal hypoglycemia during pregnancy in type 1 diabetes: maternal and fetal consequences
ter Braak, E. W. M. T., Evers, I. M., Willem Erkelens, D., & Visser, G. H. A. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.271 · Cited by 166
“glycemia was a significant risk factor for SH [36].”
BackgroundImpaired awareness of hypoglycaemia: a review
Graveling, A. J., & Frier, B. M. (2010) · Diabetes & Metabolism · doi:10.1016/s1262-3636(10)70470-5 · Cited by 160
Scott, A., Chambers, D., Goyder, E., & O’Cathain, A. (2017) · PLOS ONE · doi:10.1371/journal.pone.0177210 · Cited by 140
Hypoglycemia-associated autonomic failure in diabetes
Cryer, P. E. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1115 · Cited by 152
Type 1 diabetes: A predictable disease
Simmons, K. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.380 · Cited by 117
Akram, K., Pedersen‐Bjergaard, U., Carstensen, B., Borch‐Johnsen, K., & Thorsteinsson, B. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01880.x · Cited by 130
Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus
Fullerton, B., Siebenhofer, A., Jeitler, K., Horvath, K., Semlitsch, T., Berghold, A., Plank, J., Pieber, T. R., & Gerlach, F. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012161 · Cited by 93
Yale, J.-F., Paty, B., & Senior, P. A. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.010 · Cited by 105
Sørensen, J. S., Johannesen, J., Pociot, F., Kristensen, K., Thomsen, J., Hertel, N. T., Kjaersgaard, P., Brorsson, C., Birkebaek, N. H., & the Danish Society for Diabetes in Childhood and Adolescence (2013) · Diabetes Care · doi:10.2337/dc13-0418 · Cited by 90
Böhme, P., Bertin, É., Cosson, E., & Chevalier, N. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.10.006 · Cited by 97
Leckie, A. M., Graham, M. K., Grant, J. B., Ritchie, P. J., & Frier, B. M. (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1333 · Cited by 84
Semlitsch, T., Engler, J., Siebenhofer, A., Jeitler, K., Berghold, A., & Horvath, K. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005613.pub4 · Cited by 80
Clayton, D., Woo, V. C., & Yale, J. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.022 · Cited by 75
Fullerton, B., Siebenhofer, A., Jeitler, K., Horvath, K., Semlitsch, T., Berghold, A., & Gerlach, F. M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013228 · Cited by 72
Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus
Siebenhofer, A., Plank, J., Berghold, A., Narath, M., Gfrerer, R., & Pieber, T. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003287.pub3 · Cited by 49
Negotiating the Barrier of Hypoglycemia in Diabetes
Cryer, P. E., & Childs, B. P. (2002) · Diabetes Spectrum · doi:10.2337/diaspect.15.1.20 · Cited by 65
Classification of hypoglycemia awareness in people with type 1 diabetes in clinical practice
Høi-Hansen, T., Pedersen-Bjergaard, U., & Thorsteinsson, B. (2010) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2009.07.006 · Cited by 61
“…types of diabetes (Akram et al., 2006; Bragd et al., 2003; Clarke et al., 1995; Gold et al., 1994; Henderson et al., 2003; Hepburn et al., 1994; MacLeod et al., 1993; Mühlhauser et al., 1998; Pedersen-Bjergaard, AgerholmLarsen et al., 2003; Pedersen-Bjergaard et al., 2004; ter Braak et al., 2000).”
BackgroundBulsara, M. K., Holman, C. D. J., Davis, E. A., & Jones, T. W. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01250.x · Cited by 54
Heller, S., Lawton, J., Amiel, S., Cooke, D., Mansell, P., Brennan, A., Elliott, J., Boote, J., Emery, C., Baird, W., et al. (2014) · Programme Grants for Applied Research · doi:10.3310/pgfar02050 · Cited by 53
Hypoglycemia in type 2 diabetes
Banarer, S., & Cryer, P. E. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.003 · Cited by 55
Siebenhofer, A., Plank, J., Berghold, A., Horvath, K., Sawicki, P. T., Beck, P., & Pieber, T. R. (2004) · Diabetologia · doi:10.1007/s00125-004-1545-x · Cited by 54
“More robust definitions, such as “injection of glucose or glucagon by another person” may produce more reliable data [ 62 ].”
BackgroundReporting Severe Hypoglycemia in Type 1 Diabetes: Facts and Pitfalls
Pedersen‐Bjergaard, U., & Thorsteinsson, B. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0965-1 · Cited by 52
Hypoglycaemia unawareness and the brain
Smith, D. M., & Amiel, S. A. (2002) · Diabetologia · doi:10.1007/s00125-002-0877-7 · Cited by 52
“Certainly, although the data are incomplete, loss of glucagon responses to acute hypoglycaemia correlates well with loss of C-peptide secretion and is found in patients with advanced Type II (non-insulin-dependent) diabetes mellitus and Cpeptide negative Type I (insulin-dependent) diabetes mellitus within the first fi…”
BackgroundLenz, M., Steckelberg, A., Richter, B., & Mühlhauser, I. (2007) · Diabetologia · doi:10.1007/s00125-007-0679-z · Cited by 48
“Out of 25 [5, 33–37, 39, 41–43, 45–59] replication trials (phase 4, see text box: Phases of ‘increasing evidence of complex interventions’) four [34, 35, 39, 46] were included in six reviews [16, 19, 21, 22, 24, 25].”
Self-citationHypoglycemia: From the Laboratory to the Clinic
Amiel, S. A. (2009) · Diabetes Care · doi:10.2337/dc09-0113 · Cited by 44
“One of the best predictors is an absence of Cpeptide; another even stronger predictor is having a history of severe hypoglycemia (4).”
BackgroundSevere Hypoglycemia and Smoking in a Long-Term Type 1 Diabetic Population
Hirai, F. E., Moss, S. E., Klein, B. E. K., & Klein, R. (2007) · Diabetes Care · doi:10.2337/dc06-2264 · Cited by 42
Illness Denial in Medical Disorders: A Systematic Review
Patierno, C., Fava, G. A., & Carrozzino, D. (2023) · Psychotherapy and Psychosomatics · doi:10.1159/000531260 · Cited by 44
Prevention and Correction of Hypoglycemia: Relevance to Type 1 Diabetes
Cryer, P. E. (2003) · Type 1 Diabetes · doi:10.1007/978-1-59259-310-1_7 · Cited by 42
A retrospective study on the incidence and risk factors of severe hypoglycemia in primary care
Samann, A., Lehmann, T., Heller, T., Muller, N., Hartmann, P., Wolf, G. B., & Muller, U. A. (2013) · Family Practice · doi:10.1093/fampra/cms071 · Cited by 38
Hypoglycemia in Type 1 Diabetes Mellitus: Pathophysiology and Prevention
Dagogo-Jack, S. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403020-00004 · Cited by 40
Zammitt, N. N., Geddes, J., Warren, R. E., Marioni, R., Ashby, J. P., & Frier, B. M. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02263.x · Cited by 35
Shechter, Y., Mironchik, M., Rubinraut, S., Saul, A., Tsubery, H., & Fridkin, M. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050055w · Cited by 39
Reversible pegylation of insulin facilitates its prolonged action in vivo
Shechter, Y., Mironchik, M., Rubinraut, S., Tsubery, H., Sasson, K., Marcus, Y., & Fridkin, M. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.03.018 · Cited by 35
Ishtiak‐Ahmed, K., Carstensen, B., Pedersen‐Bjergaard, U., & Jørgensen, M. E. (2016) · Diabetes Care · doi:10.2337/dc16-0862 · Cited by 30
Zenz, S., Mader, J. K., Regittnig, W., Brunner, M., Korsatko, S., Boulgaropoulos, B., Magnes, C., Raml, R., Narath, S. H., Eller, P., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01836 · Cited by 28
Lammert, M., Hammer, M., & Frier, B. M. (2009) · Journal of Medical Economics · doi:10.3111/13696990903310501 · Cited by 30
“No complications, n (%) 26 (67) 22 (32) 20 (67) 6 (22) 13 (52) 9 (36)”
Does hypoglycemia cause cardiovascular events?
Chopra, S., & Kewal, A. (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.91203 · Cited by 29
Bragd, J., Adamson, U., Lins, P. ‐., Wredling, R., & Oskarsson, P. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00902.x · Cited by 27
Frequency, Causes and Risk Factors for Hypoglycaemia in Type 1 Diabetes
Strachan, M. W. J. (2013) · Wiley eBooks · doi:10.1002/9781118695432.ch4 · Cited by 27
Berkowitz, S. A., Aragon, K., Hines, J. Z., Seligman, H. K., Lee, S., & Sarkar, U. (2013) · Health Services Research · doi:10.1111/1475-6773.12048 · Cited by 27
“These large, well-controlled studies are consistent with other work that demonstrates the association between social vulnerability and hypoglycemia (Muhlhauser et al. 1998; Leese et al. 2003; Duran-Nah et al. 2008; Ginde, Espinola, and Camargo 2008; Wild et al. 2010), low health literacy (Sotiropoulos et al.”
ResultWalker, A., James, C., Bannister, M., & Jobes, E. (2006) · Emergency Medicine Journal · doi:10.1136/emj.2005.028548 · Cited by 27
Update on strategies limiting iatrogenic hypoglycemia
Bonaventura, A., Montecucco, F., & Dallegri, F. (2015) · Endocrine Connections · doi:10.1530/ec-15-0044 · Cited by 26
Social vulnerability and hypoglycemia among patients with diabetes
Waitman, J. N., Caeiro, G., Gonzalez, S. A. R., Ré, D. P., DAGHERO, A. V., González, C. D., & Umpierrez, G. E. (2017) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2016.11.008 · Cited by 26
Heller, S. R. (1999) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.1999.0020 · Cited by 24
Metformin Does Not Adversely Affect Hormonal and Symptomatic Responses to Recurrent Hypoglycemia
Fruehwald‐Schultes, B., Kern, W., Oltmanns, K. M., Sopke, S., Toschek, B., Born, J., Fehm, H. L., & Peters, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7790 · Cited by 23
Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes
Wellens, M. J., Vollenbrock, C. E., Dekker, P., Boesten, L. S. M., Geelhoed-Duijvestijn, P. H. L. M., de Vries, M., Nefs, G., Wolffenbuttel, B. H. R., Aanstoot, H., & van Dijk, P. R. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002288 · Cited by 21
“21 As the presence of C-peptide was associated with a lower rate of hypo-glycemia, it can be hypothesized that residual C- peptide secretion may also be associated with the absence of IAH.”
Can Continuous Glucose Monitoring Provide Objective Documentation of Hypoglycemia Unawareness?
Streja, D. A. (2005) · Endocrine Practice · doi:10.4158/ep.11.2.83 · Cited by 20
Review: Does hypoglycaemia cause cardiovascular events?
Graveling, A. J., & Frier, B. M. (2010) · The British Journal of Diabetes · doi:10.1177/1474651409355113 · Cited by 20
Lobmann, R., & Lehnert, H. (2003) · Der Internist · doi:10.1007/s00108-003-1052-z · Cited by 19
Hypoglycemia and the Hypoglycemic Unawareness Syndrome
Hirsch, I. B. (2000) · Diabetes Technology & Therapeutics · doi:10.1089/15209150050214177 · Cited by 14
Sjöberg, S., Ahrén, B., & Bolinder, J. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01043.x · Cited by 13
Sawka, A. M., Boulos, P., Talib, A. S., Gafni, A., Thabane, L., Παπαϊωάννου, Α., Booth, G. L., & Gerstein, H. C. (2007) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(07)13010-0 · Cited by 13
Lega, I. C., Yale, J.-F., Chadha, A., Paty, B., Roscoe, R., Snider, M., Steier, J., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.08.003 · Cited by 12
Repressive coping in geriatric patients’ reports – Impact on fear of falling
Hauer, K. A., Tremmel, A.-D., Ramroth, H., Pfisterer, M. H.-D., Todd, C. J., Oster, P., & Schüler, M. (2008) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-008-0552-9 · Cited by 12
Begg, I. S., Yale, J., Houlden, R. L., Rowe, R., & McSherry, J. (2003) · Cited by 12
Beta-cell transplantation in type 1 diabetic patients: a work in progress to cure.
Gillard, P., Keymeulen, B., & Mathieu, C. (2010) · PubMed · Cited by 10
Honkasalo, M., Elonheimo, O., & Sane, T. (2010) · Traffic Injury Prevention · doi:10.1080/15389581003735618 · Cited by 8
“Many previous studies have shown that an SH episode in the past is a strong independent risk factor for future SH episodes (ter Braak et al. 2000; Mattila et al. 2001; Mühlhauser et al. 1998).”
BackgroundHypoglycemia in type 1 diabetes: a burden to worry about during treatment
Dib, S. A. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000574 · Cited by 7
“As you know, the residual endogenous insulin secretion (C-peptidepositivity) is a protective factor (7), although it can be also triggered by a recent history of hypoglycemia (8), prior exercise or sleep (9).”
BackgroundPedersen‐Bjergaard, U. (2009) · PubMed · Cited by 7
Cryer, P. E. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00034-1 · Cited by 7
Allen, K. A., McAulay, V., Sommerfield, A., & Frier, B. M. (2004) · Practical Diabetes · doi:10.1002/pdi.637 · Cited by 7
Linn, T., Mann, M., Mann, M., Bretzel, R. G., & Boedeker, R. H. (2003) · BMC Endocrine Disorders · doi:10.1186/1472-6823-3-5 · Cited by 7
“It was also observed that hypoglycemia (low blood glucose concentration) – a typical side effect of the subcutaneous injection of insulin – occurred less frequently in patients with residual C-Peptide [ 6 ].”
Risk factors for hypoglycaemia in adults with type 1 diabetes: a systematic review and meta-analysis
Zhang, Q. X., Zhou, H., Lin, R., Hu, L., & Zhu, X. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02122-9 · Cited by 6
“A landmark German prospective study [24] identified insulin doses ≥ 0.5 U/kg/d as an independent hypoglycaemia predictor.”
InfluentialPatient education programmes and decision aids - evaluation of complex interventions*
Lenz, M., Steckelberg, A., & Mühlhauser, I. (2008) · Avances en Diabetología · Cited by 6
Self-citationClayton, D., Woo, V. C., & Yale, J. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.09.088 · Cited by 6
RetractedSuspensions of pro-drug insulin greatly prolong normoglycemic patterns in diabetic rats
Shechter, Y., Tsubery, H., & Fridkin, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01200-2 · Cited by 6
Kristensen, P. L., Pedersen‐Bjergaard, U., Schalkwijk, C., Olsen, N. V., & Thorsteinsson, B. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0464 · Cited by 6
Programme Grants for Applied Research
Library, N. J. (2012) · Cited by 5
Sejling, A., Wang, P., Zhu, W., Farhat, R., Knight, N. S., Appadurai, D. A., & Chan, O. T. M. (2020) · Endocrinology · doi:10.1210/endocr/bqaa241 · Cited by 5
Clayton, D., Woo, V. C., & Yale, J. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.007 · Cited by 5
Amiel, S. A., & Cryer, P. E. (2009) · Diabetes · doi:10.2337/db08-1647 · Cited by 5
Cryer, P. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00034-4 · Cited by 5
Liu, W., McGuire, H., Kissimova‐Skarbek, K., Zhou, X., Han, X., Wang, Y., Jaacks, L. M., Zhang, S., Lin, S., & Ji, L. (2019) · Endocrine Research · doi:10.1080/07435800.2019.1624567 · Cited by 5
Icks, A., Haastert, B., Rathmann, W., Rosenbauer, J., & Giani, G. (2006) · American Journal of Public Health · doi:10.2105/ajph.2005.063339 · Cited by 5
Ganz, M. L., Li, Q., Wintfeld, N., Lee, Y.-C., SORLI, C. H., & Huang, J. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1074891 · Cited by 4
Social vulnerability and hypoglycemia among patients with diabetes
Waitman, J. N., Caeiro, G., Gonzalez, S. A. R., Ré, D. P., DAGHERO, A. V., González, C. D., & Umpierrez, G. E. (2017) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2017.03.002 · Cited by 4
Evidence Report: 2010 Update: Diabetes and Commercial Motor Vehicle Driver Safety [May 27 2011]
Tregear, S., Tiller, M., Bieber-Tregear, M., Connor, D., Funmilayo, D., & Amana, A. (2011) · ROSA P · Cited by 3
Impact of the TCF7L2 genotype on risk of hypoglycaemia and glucagon secretion during hypoglycaemia
Kristensen, P. L., Pedersen‐Bjergaard, U., Due-Andersen, R., Høi-Hansen, T., Bie-Olsen, L. G., Lyssenko, V., Groop, L., Holst, J. J., Vaag, A. A., & Thorsteinsson, B. (2016) · Endocrine Connections · doi:10.1530/ec-16-0050 · Cited by 2
Stratifying Hypoglycaemic Event Risk in Insulin-treated Diabetes
Heller, S. R. (2006) · Cited by 2
Clinical studies of glucose variability and hypoglycemia in adult patients with type 1 diabetes
Bragd, J. (2011) · Figshare · Cited by 2
Cryer, P. E., & Frier, B. M. (2004) · International Textbook of Diabetes Mellitus · doi:10.1002/0470862092.d0707 · Cited by 1
Гипогликемия и гипогликемическая кома
Старостина, Е. Г. (2019) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2013-5-6-6-10 · Cited by 1
Kristensen, P. L., Pedersen‐Bjergaard, U., Olsen, N. V., Schalkwijk, C., & Thorsteinsson, B. (2010) · 12th European Congress of Endocrinology · Cited by 1
Metadata
- Authors
- Mühlhauser, I., Overmann, H., Bender, R., Bott, U., & Berger, M.
- Affiliations
- Heinrich Heine University Düsseldorf (DE)
- ORCID
- Venue
- Diabetologia
- Published
- 1998-10-20
- Volume
- 41
- Issue
- 11
- Pages
- 1274-1282
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1980796462
- Cited by
- 117
- References
- 24
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 4 · 2016: 4 · 2015: 5 · 2014: 2 · 2013: 7 · 2012: 5
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Keywords
- severe hypoglycemia, type 1 diabetes, risk factors, social status, social class, hypoglycemia awareness
- MeSH terms
- Adult, Aged, Blood Glucose, Demography, Diabetes Mellitus, Type 1, Dietary Carbohydrates, Female, Germany, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Interviews as Topic, Male, Middle Aged, Perception, Pregnancy, Pregnancy in Diabetics, Risk Factors, Social Class, Blood Glucose Self-Monitoring, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.